{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:13:49Z","timestamp":1787688829888,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.antiviral.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T19:38:52Z","timestamp":1432150732000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Characterizing the effect of Bortezomib on Rift Valley Fever Virus multiplication"],"prefix":"10.1016","volume":"120","author":[{"given":"Forrest","family":"Keck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moushimi","family":"Amaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylene","family":"Kehn-Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthi","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.05.004_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1081\/CNV-120030218","article-title":"Development of the proteasome inhibitor Velcade (Bortezomib)","volume":"22","author":"Adams","year":"2004","journal-title":"Cancer Invest."},{"key":"10.1016\/j.antiviral.2015.05.004_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086745","article-title":"The role of IKK\u03b2 in Venezuelan equine encephalitis virus infection","volume":"9","author":"Amaya","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.05.004_b0015","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1074\/jbc.M111.296608","article-title":"Induction of DNA damage signaling upon Rift Valley Fever Virus infection results in cell cycle arrest and increased viral replication","volume":"287","author":"Baer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.004_b0020","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/AAC.01101-09","article-title":"Bortezomib inhibits hepatitis B virus replication in transgenic mice","volume":"54","author":"Bandi","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.05.004_b0025","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley Fever Virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0030","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift Valley Fever Virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0035","first-page":"8","article-title":"Molecular biology of Rift Valley Fever Virus","volume":"4","author":"Bouloy","year":"2010","journal-title":"Open Virol. J."},{"key":"10.1016\/j.antiviral.2015.05.004_b0040","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley Fever Virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0045","unstructured":"CellTiter-Glo Luminescent Cell Viability Assay, 2012."},{"key":"10.1016\/j.antiviral.2015.05.004_b0050","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1128\/JVI.00533-10","article-title":"The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state","volume":"84","author":"Dudek","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0055","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of Rift Valley Fever Virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley Fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2015.05.004_b0065","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1111\/j.1749-6632.2009.05054.x","article-title":"Dual functions of Rift Valley Fever Virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR","volume":"1171","author":"Ikegami","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2015.05.004_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley Fever Virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2? Phosphorylation","volume":"5","author":"Ikegami","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.05.004_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2012.00131","article-title":"Novel approaches to develop Rift Valley fever vaccines","volume":"2","author":"Indran","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0080","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1128\/JVI.02914-13","article-title":"Virulence factor NSs of Rift Valley Fever Virus recruits the F-Box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH","volume":"88","author":"Kainulainen","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0085","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1128\/JVI.02255-10","article-title":"NSs protein of Rift Valley Fever Virus promotes posttranslational downregulation of the TFIIH subunit p62","volume":"85","author":"Kalveram","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(04)00132-1","article-title":"TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus","volume":"116","author":"Le May","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2015.05.004_b0095","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.ppat.0040013","article-title":"A SAP30 complex inhibits IFN-\u03b2 expression in Rift Valley Fever Virus infected cells","volume":"4","author":"Le May","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.05.004_b0100","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JVI.01165-09","article-title":"Nonstructural NSs protein of Rift Valley Fever Virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects","volume":"84","author":"Mansuroglu","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0105","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1158\/0008-5472.CAN-07-6246","article-title":"Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo","volume":"68","author":"Milacic","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2015.05.004_b0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.virol.2013.11.023","article-title":"Reactive oxygen species activate NF\u03baB (p65) and p53 and induce apoptosis in RVFV infected liver cells","volume":"449","author":"Narayanan","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.05.004_b0115","doi-asserted-by":"crossref","first-page":"33198","DOI":"10.1074\/jbc.M112.356535","article-title":"Curcumin inhibits Rift Valley Fever Virus replication in human cells","volume":"287","author":"Narayanan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.004_b0120","doi-asserted-by":"crossref","first-page":"e20354","DOI":"10.1371\/journal.pone.0020354","article-title":"Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection","volume":"6","author":"Narayanan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.05.004_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093483","article-title":"Multi-faceted proteomic characterization of host protein complement of Rift Valley Fever Virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors","volume":"9","author":"Nuss","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.05.004_b0130","doi-asserted-by":"crossref","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley Fever Virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2015.05.004_b0135","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cbpa.2004.09.009","article-title":"Polyubiquitin chains: polymeric protein signals","volume":"8","author":"Pickart","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013805","article-title":"Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift Valley Fever Virus in human small airway epithelial cells","volume":"5","author":"Popova","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.05.004_b0145","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1128\/JVI.00485-10","article-title":"The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle","volume":"84","author":"Raaben","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/prot.22555","article-title":"Identification, analysis, and prediction of protein ubiquitination sites","volume":"78","author":"Radivojac","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2015.05.004_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002296","article-title":"The use of nanotrap particles as a sample enrichment method to enhance the detection of Rift Valley Fever Virus","volume":"7","author":"Shafagati","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2015.05.004_b0160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1099\/0022-1317-60-2-381","article-title":"Identification of a major non-structural protein in the nuclei of Rift Valley Fever Virus-infected cells","volume":"60","author":"Struthers","year":"1982","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0165","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1099\/0022-1317-34-3-557","article-title":"Demonstration of nuclear immunofluorescence in Rift Valley Fever Infected Cells","volume":"34","author":"Swanepoel","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0170","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/JVI.01753-08","article-title":"Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication","volume":"83","author":"Teale","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0175","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of Rift Valley Fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"Vialat","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.004_b0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(97)00097-X","article-title":"Mapping of the mutations present in the genome of the Rift Valley Fever Virus attenuated MP12 strain and their putative role in attenuation","volume":"52","author":"Vialat","year":"1997","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.05.004_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001186","article-title":"Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.05.004_b0190","doi-asserted-by":"crossref","first-page":"9942","DOI":"10.1074\/jbc.272.15.9942","article-title":"Regulation of I\u03baB\u03b2 degradation Similarities to and differences from I\u03baB\u03b1","volume":"272","author":"Weil","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.004_b0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2009.01.041","article-title":"Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:23:30Z","timestamp":1537622610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":39,"alternative-id":["S0166354215001242"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing the effect of Bortezomib on Rift Valley Fever Virus multiplication","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}